Suominen introduces FIBRELLA™ Perf for the South American markets

Suominen Corporation   Press release   3 March 2015 at 12:00 pm EET

SUOMINEN INTRODUCES FIBRELLA™ PERF FOR THE SOUTH AMERICAN MARKETS

Suominen, a leading global supplier of nonwovens, introduces FIBRELLA™ Perf Spunlace, a new range of apertured substrates for the South American medical markets. Fibrella™ Perf product range offers solutions suitable for traditional and advanced wound care as well as surgical applications.

Fibrella™ Perf nonwovens feature superior levels of safety, softness, and comfort. Being breathable, skin-friendly, low-linting and very absorbent, Fibrella™ Perf has all the properties required of a best-in-class wound care product. In surgical laminates and apparel Fibrella Perf™ offers excellent liquid transfer properties and absorbency. In addition, Fibrella™ Perf range offers choice for various sterilization methods.

“Suominen’s Fibrella™ products have served the medical markets in wound care and surgical products already for decades in Europe and North America. Now we are able to even better serve our customers in South America as we will start local production of Fibrella™ Perf at our Paulínia plant in Brazil,” says Marika Mäkilä, Product Manager for Medical applications.

“Fibrella™ Perf product range will be launched in OUTLOOK™ Plus Latin America 2015 in Sao Paulo on 3 March and will be available as of Q4/2015," Mäkilä concludes.

For additional information, please contact Marika Mäkilä, Product Manager, tel. +358 50 384 4014, marika.makila@suominencorp.com.

 

Suominen in brief

Suominen manufactures nonwovens as roll goods for wipes as well as for medical and hygiene products. The end products made of Suominen’s nonwovens – wet wipes, feminine care products and swabs, for instance - bring added value to the daily life of consumers worldwide. Suominen is the global market leader in nonwovens for wipes and employs approximately 600 people in Europe and in the Americas. Suominen’s net sales in 2014 amounted to MEUR 401.8 and operating profit excluding non-recurring items to MEUR 26.9 (continuing operations). The Suominen share (SUY1V) is listed in NASDAQ OMX Helsinki Stock Exchange. Read more at www.suominen.fi.

Latest news

Directors and Officers, European Regulatory News
STOCK EXCHANGE RELEASE December 5, 2024

Mark Ushpol appointed EVP, Americas business area at Suominen

Directors and Officers, European Regulatory News
STOCK EXCHANGE RELEASE October 21, 2024

Minna Rouru appointed Chief People & Communications Officer at Suominen